MG
RVNC

Mather Group’s Revance Therapeutics, Inc. RVNC Stock Holding History

Mather Group’s Portfolio RVNC Stock Details RVNC Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change % 		Capital Flow Portfolio Weight Portfolio Position
2024
Q4 		– Sell
-700
Closed -$3.63K – 1802
2024
Q3 		$3.63K Sell
700
-300
-30% -$1.56K ﹤0.01% 1362
2024
Q2 		$4.92K Buy
1,000
+300
+43% +$1.48K ﹤0.01% 1626
2024
Q1 		$6.15K Buy
+700
New +$6.15K ﹤0.01% 1311